Telemedicine App CloudMD Launches In Ontario As Coronavirus Concerns Increase Need For Digital Healthcare

VANCOUVER, British Columbia, March 31, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:PHGRF)(Frankfurt: 6PH) (the “Company” or “CloudMD”), a company focused on digitizing the delivery of healthcare, has expanded its direct-to-consumer telemedicine app, CloudMD, to service Ontarians.

The app, which is free to download and use, allows people to book same-day appointments with a licensed physician in their own province. A roster of Ontario physicians has been onboarded to address Ontarians’ health concerns via secure, real-time videoconferencing on the app.

There has been a growing demand for digital health care, as demonstrated by the positive reception CloudMD received from its launch in British Columbia earlier this year. Then came the coronavirus pandemic. As Canadians settled into their self-isolation routines, they have shown more motivation to seek medical advice virtually, preferring to avoid emergency rooms and clinics. According to the team of physicians behind the B.C.-based telehealth platform, CloudMD has been averaging more than 110 consultations a day since the start of the coronavirus self-isolation period. In fact, in the past two weeks, CloudMD has seen a 69 percent increase in inpatient consultations. Last week, patient consultations were up by 83 percent compared to the first week of March.

Ontario announces an emergency telemedicine billing code

Earlier this month, the province of Ontario announced an emergency telemedicine billing code, allowing patients to be billed through OHIP. Telemedicine provides a vital service because it increases capacity at hospitals that were already operating beyond capacity pre-coronavirus. It also provides convenient access to physicians for all Ontarians covered under OHIP.

Dr. Essam Hamza, CEO of CloudMD, sees the quick response of provincial governments to adopt telemedicine consultations as a positive reinforcement for the future of digital healthcare.

“The coronavirus pandemic has transformed public behavior faster than ever before, and in response, we’re seeing government move at uncharacteristic speed to adapt to this ‘new normal’ we find ourselves in,” explains Dr. Hamza. “With many global forecasts predicting the coronavirus crisis will last until spring 2021, this is our opportunity to show the benefits of telemedicine, and how it can be used effectively to receive timely care and reduce strain on hospital resources while minimizing the outbreak’s spread.”

CloudMD is now available free to download at the App Store and Google Play.

Quick facts about CloudMD

  • The app is now available to 20 million patients in B.C. and Ontario.
  • Service is available seven days a week, Monday to Friday 9am – 7pm and Saturday and Sunday 9am – 5pm.
  • The number of patient consultations on the app has increased by over 69 percent in just the last two weeks.
  • There has been a 71 percent increase in app downloads since the start of the coronavirus self-isolation period in Canada.

About CloudMD Software & Services Inc.

CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:PHGRF)(Frankfurt: 6PH) is digitizing the delivery of healthcare by providing patients access to all points of care from their phone, tablet or desktop computer. The Company offers SAAS based health technology solutions to medical clinics across Canada and has developed proprietary technology that delivers quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). CloudMD currently has a combined ecosystem of 315 clinics, over 3000 licensed practitioners and almost 3 million registered patients.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Please See Disclaimer


Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of a third party, CloudMD Software & Services Inc. Market Jar Media Inc. expects to receive the following amounts from Native Ads Inc. in the amount of one hundred eight thousand and eight hundred CAD Dollars for 76 campaign days (54 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.